The Safety of Edaravone for patients with Amyotrophic Lateral Sclerosis: Single centered open label trial
Phase of Trial: Phase I/II
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Edaravone (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 03 Aug 2016 Status changed from active, no longer recruiting to discontinued.
- 25 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 06 Feb 2015 New trial record